Evidence map›Paper›PMID 31646007›Full record

ArticleBMJ global health2019

Tracking development assistance for health from China, 2007-2017.

Angela E Micah, Yingxi Zhao, Catherine S Chen, Bianca S Zlavog, Golsum Tsakalos, Abigail Chapin, Stephen Gloyd, Jost Jonas, Paul H Lee, Shiwei Liu and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Angela E Micah *Institute for Health Metrics and Evaluation, Seattle, Washington, USA.ORCID 0000-0002-0190-1017
Yingxi Zhao *Institute for Health Metrics and Evaluation, Seattle, Washington, USA.
Catherine S ChenInstitute for Health Metrics and Evaluation, Seattle, Washington, USA.
Bianca S ZlavogInstitute for Health Metrics and Evaluation, Seattle, Washington, USA.
Golsum TsakalosInstitute for Health Metrics and Evaluation, Seattle, Washington, USA.
Abigail ChapinInstitute for Health Metrics and Evaluation, Seattle, Washington, USA.
Stephen GloydDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Jost JonasOphthalmology, Medical Faculty Mannheim of the Ruprecht Karl University of Heidelberg, Mannheim, Germany.ORCID 0000-0003-2972-5227
Paul H LeeSchool of Nursing, Hong Kong Polytechnic University, Hong Kong, China.ORCID 0000-0002-5729-6450
Shiwei LiuNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, Hubei, China.
Man Tat Alexander NgTencent Healthcare, Shenzhen, Guangdong, China.
Michael R PhillipsShanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China.
Enrico RubagottiBiotechnology, Universidad Regional Amazónica Ikiam, Ciudad de Tena, Napo, Ecuador.
Kun TangResearch Center for Public Health, Tsinghua University School of Medicine, Beijing, Hubei, China.ORCID 0000-0002-5444-186X
Shenglan TangDuke Global Health Institute, Duke University, Durham, North Carolina, USA.
Mustafa YounisDepartment of Health Economics & Management, Jackson State University, Jackson, Mississippi, USA.
Yunquan ZhangHubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Public Health, Wuhan University of Science and Technology, Wuhan, Hubei, China.ORCID 0000-0002-2618-5088
Christopher J L MurrayInstitute for Health Metrics and Evaluation, Seattle, Washington, USA.
Joseph L DielemanInstitute for Health Metrics and Evaluation, Seattle, Washington, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn recent years, China has increased its international engagement in health. Nonetheless, the lack of data on contributions has limited efforts to examine contributions from China. Existing estimates that track development assistance for health (DAH) from China have relied primarily on one dataset. Furthermore, little is known about the disbursing agencies especially the multilaterals through which contributions are disbursed and how these are changing across time. In this study, we generated estimates of DAH from China from 2007 through 2017 and disaggregated those estimates by disbursing agency and health focus area.

methodsWe identified the major government agencies providing DAH. To estimate DAH provided by each agency, we leveraged publicly available development assistance data in government agencies' budgets and financial accounts, as well as revenue statements from key international development agencies such as the WHO. We reported trends in DAH from China, disaggregated contributions by disbursing bilateral and multilateral agencies, and compared DAH from China with other traditional donors. We also compared these estimates with existing estimates.

resultsDAH provided by China grew dramatically, from US$323.1 million in 2007 to $652.3 million in 2017. During this period, 91.8% of DAH from China was disbursed through its bilateral agencies, including the Ministry of Commerce ($3.7 billion, 64.1%) and the National Health Commission ($917.1 million, 16.1%); the other 8.2% was disbursed through multilateral agencies including the WHO ($236.5 million, 4.1%) and the World Bank ($123.1 million, 2.2%). Relative to its level of economic development, China provided substantially more DAH than would be expected. However, relative to population size and government spending, China's contributions are modest.

conclusionIn the current context of plateauing in the growth rate of DAH contributions, China has the potential to contribute to future global health financing, especially financing for health system strengthening.

Indexed as

Health economicsHealth policyHealth systems

Identifiers

PMID31646007
PMCPMC6782043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.